Β-OHB Supplementation and Brain Health in Older Adults

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Subjective Cognitive Decline
Interventions
DIETARY_SUPPLEMENT

Ketone monoester (KME) supplement

15g of a KME supplement orally consumed 3x daily for 14 days. This dosing protocol raises plasma β-OHB consistently during the waking hours. Oral KME will be provided in opaque bottles labelled A or B to maintain condition blinding. Each bottle will contain a drink providing 15g of a KME supplement: \[R\]-3-hydroxybutyl \[R\]-3-hydroxybutyrate (ΔG®, TDeltaS, Oxford, UK).

DIETARY_SUPPLEMENT

Placebo supplement

50mL taste-match inert calorie-free placebo drink orally consumed 3x daily for 14 days. Oral placebo will be provided in opaque bottles labelled A or B to maintain condition blinding.

Trial Locations (1)

L8S 4K1

McMaster University, Hamilton

All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

lead

McMaster University

OTHER